Home
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
中国 — 简体中文
Global — English
Home
Technology Platforms
BACK
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
BACK
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
BACK
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
BACK
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
BACK
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
BACK
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
Investor Relations
Effective Communication Drives Development
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Home
>
Investor Relations
>
Disclosure
Disclosure
Listing Documents
Financial Report/ESG information
Announcement & Notice
IR Journal
2026-05-08
VOLUNTARY ANNOUNCEMENT - U.S. FDA IND CLEARANCE FOR HBM7004 FOR THE TREATMENT OF ADVANCED SOLID TUMORS
2026-05-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
2026-05-07
Next Day Disclosure Return
2026-05-06
Next Day Disclosure Return
2026-05-05
Next Day Disclosure Return
2026-05-04
Next Day Disclosure Return
2026-04-29
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS - NOTIFICATION OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR AND NOTICE OF AGM
2026-04-29
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR, PROXY FORM AND NOTICE OF AGM
2026-04-29
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
2026-04-29
NOTICE OF ANNUAL GENERAL MEETING
2026-04-29
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING
2026-04-10
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
2026-04-09
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
2026-03-31
GRANT OF SHARE AWARDS
2026-03-30
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
2026-03-18
DATE OF BOARD MEETING
2026-03-09
VOLUNTARY ANNOUNCEMENT - APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FOR HBM7575 FOR ATOPIC DERMATITIS BY THE NMPA
2026-03-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
2026-02-23
VOLUNTARY ANNOUNCEMENT - ENTERING INTO LICENSE AGREEMENT AND EQUITY PARTNERSHIP AGREEMENT WITH SOLSTICE ONCOLOGY FOR HBM4003
2026-02-16
CLARIFICATION ANNOUNCEMENT
1
2
···
21
Jump